Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
about
Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulationsMacrocyclic protease inhibitors with reduced peptide characterBACE1 (β-secretase) inhibitors for the treatment of Alzheimer's diseaseExploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE).Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors.The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011).The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors.BACE-1 inhibition prevents the γ-secretase inhibitor evoked Aβ rise in human neuroblastoma SH-SY5Y cells2,2',4'-trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice.The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing.Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors.Base catalysed synthesis of thiochromans and azo-linked chromenes using allenylphosphonates.Chemometric design to explore pharmacophore features of BACE inhibitors for controlling Alzheimer's disease.
P2860
Q27676370-E0183A5D-4D9B-43ED-A86D-F19AE9841AA4Q27690658-1EEC246B-501A-4B92-B1C2-F6064200D28FQ34156758-C3858C06-81D0-4534-93ED-7632043DD187Q34394583-258147AF-80CD-44FD-81DD-1222B3B2AE38Q37866692-65BDA5A3-AEEE-47F6-B0A3-0D969110FA56Q37896029-F153B46C-0890-4AC9-BA6A-AA03374371F2Q38003497-300C4EEE-FF75-47A2-8F8B-D21B57CD77C2Q38127826-04D7819E-4E67-4D3E-8FEC-0D7AA53BC3CFQ39155955-F1481D57-10CF-4EC7-8064-7DFB4A8A6EABQ39711842-F9B36D5F-191F-4E56-9781-8E1BDAEF6218Q45901500-EB8C939B-A3C8-45F9-8FE9-6BEA693A0EE4Q46505177-B8C37347-A643-4DE1-9936-D2273505CDFEQ50504171-472BF8C9-324E-481D-A53A-C245D5E7D51FQ53000363-B38ADAE2-DC18-4D64-A97A-579A2B968CED
P2860
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@ast
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@en
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@nl
type
label
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@ast
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@en
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@nl
prefLabel
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@ast
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@en
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@nl
P2093
P1476
Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo
@en
P2093
Anne-Lise Jaton
Claudia Betschart
Jean-Michel Rondeau
Kurt Laumen
Marina Tintelnot-Blomley
Rainer Machauer
Sabine Rabe
Sandrine Desrayaud
Siem Veenstra
Ulf Neumann
P304
P356
10.1016/J.BMCL.2009.01.055
P407
P577
2009-01-22T00:00:00Z